Alzheon, Inc.

Alzheon, Inc.

Biotechnology Research Framingham, Massachusetts, United States 33 employees
Employees
33
Contacts
4
Emails
4
Phones
4

Alzheon, Inc. Overview

Headquarters
Framingham, Massachusetts, United States
Phone Number
Available in AeroLeads
Website
alzheon.com
Industry
Biotechnology Research
Employees
33
Founded
2013
Funding
100.0M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Alzheon, Inc.

Alzheon, Inc. is committed to developing innovative medicines by directly addressing the underlying pathology of devastating neurodegenerative disorders. Our lead Alzheimer’s clinical candidate, ALZ-801, is an oral small molecule prodrug of tramiprosate that fully blocks formation of neurotoxic soluble amyloid oligomers in the brain. ALZ-801 is an easy-to-take tablet that builds on the safety and efficacy profile of its active compound tramiprosate, which has been evaluated in clinical trials involving over 2,000 Alzheimer’s patients. Our clinical expertise and technology platform are focused on developing drug candidates using a precision medicine approach based on individual genetic and biological information to advance therapies with the greatest impact for patients. www.alzheon.com

Alzheon, Inc. Contact Details

People in AeroLeads
4
With contact data
4
Email contacts
4
100.0% coverage
Phone contacts
4
100.0% coverage

Alzheon, Inc. Org Chart

Sample employees and titles
Name Title Contact
Art Rosenthal Head of Regulatory Affairs @ Alzheon
Email Phone
Martin Tolar, Md, Phd Founder, President & CEO at Alzheon
Email Phone
Jean Schaefer VP Cmc Operations & Project Management
Email Phone
Audrey Rossow Experienced Senior Clinical Operations
Email Phone

Employees by Management Level

VP / Head 3 profiles
Executive 1 profile
Manager 1 profile
Senior / Lead 1 profile
Associate / junior 1 profile

Department Contact Coverage

Department Contacts Email Phone
Finance 1 1 1

Compare Similar Companies to Alzheon, Inc.